About the Company
We do not have any company description for GeneDx Holdings Corp. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $WGS News
Why GeneDx Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket
Shares of GeneDx Holdings Corp. (NASDAQ:WGS) rose sharply in today's pre-market trading after the company reported ...
GeneDx Holdings Corp. (WGS) Reports Q1 Loss, Tops Revenue Estimates
GeneDx Holdings Corp. (WGS) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.68. This compares to loss of $2.82 per share a year ago.
GeneDx Holdings Corp. Wt
Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...
GeneDx Stock Climbs After Better-Than-Expected Q1 Results, Raises FY24 Guidance
GeneDx Holdings Corp. (NASDAQ:WGS) shares are soaring after the company reported its first-quarter financial results after ...
GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
STAMFORD, Conn., April 29, 2024 (GLOBE NEWSWIRE) -- GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial ...
GeneDx Holdings Corp Ordinary Shares - Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
GeneDx Holdings Corp. (NASDAQ:WGS) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
GeneDx Holdings Corp. (NASDAQ:WGS) investors will be delighted, with the company turning in some strong numbers with its latest results. The results were impressive, with revenues of US$62m ...
GeneDx Holdings Corp.: GeneDx Announces Partnership with Komodo Health to Expand Access to World's Largest Rare Disease Dataset
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a strategic partnership with Komodo ...
GeneDx Rallies After Boosting '24 Revenue View
By Rob Curran GeneDx Holdings rallied after the genetic-testing firm boosted its 2024 revenue projections late Monday. The testing firm said it was ...
Loading the latest forecasts...